Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size

This study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caroline D. Hoemann, Javier Rodríguez González, Jessica Guzmán-Morales, Gaoping Chen, Ebrahim Jalali Dil, Basil D. Favis
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2022
Materias:
Acceso en línea:https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:337e6ff2ce3243578603850bfdbb4e6f
record_format dspace
spelling oai:doaj.org-article:337e6ff2ce3243578603850bfdbb4e6f2021-11-28T04:35:38ZChitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size2452-199X10.1016/j.bioactmat.2021.09.012https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f2022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452199X21004291https://doaj.org/toc/2452-199XThis study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% DDA chitosan microparticles (83-99-PCL) to accelerate angiogenesis. New Zealand White rabbit osteochondral knee defects were press-fit with PCL, 99-PCL, 83-99-PCL, or allowed to bleed (drill-only). Between day 1 and 6 weeks of repair, drill-only defects repaired by endochondral ossification, with an 8-fold higher bone volume fraction (BVF) versus initial defects, compared to a 2-fold (99-PCL), 1.1-fold (PCL), or 0.4-fold (83-99-PCL) change in BVF. Hematoma innate immune cells swarmed to 83-99-PCL, elicited angiogenesis throughout the pores and induced slight bone resorption. PCL and 99-PCL pores were variably filled with cartilage or avascular mesenchyme near the bone plate, or angiogenic mesenchyme into which repairing trabecular bone infiltrated up to 1 mm deep. More repair cartilage covered the 99-PCL scaffold (65%) than PCL (18%) or 83-99-PCL (0%) (p < 0.005). We report the novel finding that non-inflammatory chitosan coatings promoted cartilage infiltration into and over a bioplastic scaffold, and were compatible with trabecular bone integration. This study also revealed that in vitro osteogenesis assays have limited ability to predict osseous integration into porous scaffolds, because (1) in vivo, woven bone integrates from the leading edge of regenerating trabecular bone and not from mesenchymal cells adhering to scaffold surfaces, and (2) bioactive coatings that attract inflammatory cells induce bone resorption.Caroline D. HoemannJavier Rodríguez GonzálezJessica Guzmán-MoralesGaoping ChenEbrahim Jalali DilBasil D. FavisKeAi Communications Co., Ltd.articleBone tissue engineeringCartilage tissue engineeringHematomaChitosanAngiogenesisOsteogenesisMaterials of engineering and construction. Mechanics of materialsTA401-492Biology (General)QH301-705.5ENBioactive Materials, Vol 10, Iss , Pp 430-442 (2022)
institution DOAJ
collection DOAJ
language EN
topic Bone tissue engineering
Cartilage tissue engineering
Hematoma
Chitosan
Angiogenesis
Osteogenesis
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
spellingShingle Bone tissue engineering
Cartilage tissue engineering
Hematoma
Chitosan
Angiogenesis
Osteogenesis
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
Caroline D. Hoemann
Javier Rodríguez González
Jessica Guzmán-Morales
Gaoping Chen
Ebrahim Jalali Dil
Basil D. Favis
Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
description This study tested whether osseous integration into poly (ε-caprolactone) (PCL) bioplastic scaffolds with fully-interconnecting 155 ± 8 μm pores is enhanced by an adhesive, non-inflammatory 99% degree of deacetylation (DDA) chitosan coating (99-PCL), or further incorporation of pro-inflammatory 83% DDA chitosan microparticles (83-99-PCL) to accelerate angiogenesis. New Zealand White rabbit osteochondral knee defects were press-fit with PCL, 99-PCL, 83-99-PCL, or allowed to bleed (drill-only). Between day 1 and 6 weeks of repair, drill-only defects repaired by endochondral ossification, with an 8-fold higher bone volume fraction (BVF) versus initial defects, compared to a 2-fold (99-PCL), 1.1-fold (PCL), or 0.4-fold (83-99-PCL) change in BVF. Hematoma innate immune cells swarmed to 83-99-PCL, elicited angiogenesis throughout the pores and induced slight bone resorption. PCL and 99-PCL pores were variably filled with cartilage or avascular mesenchyme near the bone plate, or angiogenic mesenchyme into which repairing trabecular bone infiltrated up to 1 mm deep. More repair cartilage covered the 99-PCL scaffold (65%) than PCL (18%) or 83-99-PCL (0%) (p < 0.005). We report the novel finding that non-inflammatory chitosan coatings promoted cartilage infiltration into and over a bioplastic scaffold, and were compatible with trabecular bone integration. This study also revealed that in vitro osteogenesis assays have limited ability to predict osseous integration into porous scaffolds, because (1) in vivo, woven bone integrates from the leading edge of regenerating trabecular bone and not from mesenchymal cells adhering to scaffold surfaces, and (2) bioactive coatings that attract inflammatory cells induce bone resorption.
format article
author Caroline D. Hoemann
Javier Rodríguez González
Jessica Guzmán-Morales
Gaoping Chen
Ebrahim Jalali Dil
Basil D. Favis
author_facet Caroline D. Hoemann
Javier Rodríguez González
Jessica Guzmán-Morales
Gaoping Chen
Ebrahim Jalali Dil
Basil D. Favis
author_sort Caroline D. Hoemann
title Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
title_short Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
title_full Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
title_fullStr Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
title_full_unstemmed Chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
title_sort chitosan coatings with distinct innate immune bioactivities differentially stimulate angiogenesis, osteogenesis and chondrogenesis in poly-caprolactone scaffolds with controlled interconnecting pore size
publisher KeAi Communications Co., Ltd.
publishDate 2022
url https://doaj.org/article/337e6ff2ce3243578603850bfdbb4e6f
work_keys_str_mv AT carolinedhoemann chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
AT javierrodriguezgonzalez chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
AT jessicaguzmanmorales chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
AT gaopingchen chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
AT ebrahimjalalidil chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
AT basildfavis chitosancoatingswithdistinctinnateimmunebioactivitiesdifferentiallystimulateangiogenesisosteogenesisandchondrogenesisinpolycaprolactonescaffoldswithcontrolledinterconnectingporesize
_version_ 1718408309241806848